Picture of Laboratory of America Holdings logo

LH Laboratory of America Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Annual cashflow statement for Laboratory of America Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line8251,5572,3801,281419
Depreciation
Deferred Taxes
Non-Cash Items308858325627771
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-294-857-264-603-362
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities1,4452,1353,1101,9561,328
Capital Expenditures-400-382-460-482-454
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-883-262-424-1,170-718
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,283-643-885-1,652-1,172
Financing Cash Flow Items-77.5-61.1-74-77.61,440
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-253-517-2,066-1,322-59.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-89.3983152-1,043107